SCHEMBL22985294

SCHEMBL22985294

Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3ccc(C#N)cc3C(F)(F)F)c(-c3cc(C#N)ccc3-n3c4ccccc4c4cc(-c5ccc(C)cc5C)ccc43)c2)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.35
PTGER4 P35408 1/20 0.32
PDPK1 O15530 1/20 0.31
ELANE P08246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985638 0.96 AR (0.33) ARELANE
SCHEMBL20849073 0.95 AR (0.33) ARPTGER4ELANE
SCHEMBL22985588 0.93 AR (0.42) ARPTGER4PDPK1ELANE
SCHEMBL22985054 0.92 AR (0.36) ARPTGER4PDPK1ELANE
SCHEMBL22985158 0.92 AR (0.33) ARELANE
SCHEMBL20849491 0.92 AR (0.34) ARPTGER4PDPK1ELANE
SCHEMBL22985385 0.91 AR (0.37) ARPTGER4ELANE
SCHEMBL22985002 0.91 AR (0.38) ARPTGER4PDPK1ELANE
SCHEMBL22984981 0.91 AR (0.39) ARPTGER4PDPK1
SCHEMBL22985580 0.91 AR (0.40) ARPTGER4PDPK1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885PTGER4 3301/4885PDPK1 2545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.